Time to Treatment Discontinuation in German Patients with Schizophrenia: Long-Acting Injectables versus Oral Antipsychotics.
Joerg MahlichKerstin OlbrichAdrian WilkAntonie WimmerClaus Wolff-MenzlerPublished in: Clinical drug investigation (2020)
This real-world study associates LAIs with better medication adherence and lower antipsychotic discontinuation risk than OAPs.
Keyphrases